The lack of benefit and the potential negative side effects of beta blockers are overstated, especially in the elderly. This emphasis has led to recommendations by some investigators that these agents not be used in the management of @entity101 in this age group. There are numerous reasons why these recommendations should not be followed. The use of beta blockers in the elderly @entity101 has resulted in a reduction in @entity64 and @entity712 . In addition, it should be emphasized that elderly @entity1 are more likely to have silent @entity453 or sustain @entity583 . There is abundant evidence that beta blockers are effective therapy in reducing mortality once a @entity583 has occurred. In fact, there is a clear reduction in @entity1164 . Furthermore, national statistics document that elderly @entity1 have a prevalence of @entity712 that varies from 6%-10%. Multiple studies have now documented that beta blockers are additive to @entity1289 inhibitors in reducing mortality for @entity712 . Thus, elderly @entity101 @entity1 may benefit from the use of beta blockers, especially if there is evidence of @entity741 , @entity943 , or @entity712 .

Should beta blockers be used in the treatment of XXXX in the elderly?

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1164 :: ('MESH:D016757', 'Disease') :: ['sudden cardiac death'] @entity712 :: ('MESH:D006333', 'Disease') :: ['congestive heart failure'] @entity64 :: ('MESH:D020521', 'Disease') :: ['strokes'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension', 'hypertensive'] @entity583 :: ('MESH:D009203', 'Disease') :: ['myocardial infarction', 'myocardial infarctions'] @entity1289 :: ('1636', 'Gene') :: ['angiotensin-converting enzyme'] @entity741 :: ('MESH:D017202', 'Disease') :: ['ischemic heart disease'] @entity453 :: ('MESH:D003324', 'Disease') :: ['coronary artery disease'] @entity943 :: ('MESH:D001145', 'Disease') :: ['cardiac arrhythmias']
@entity101 :: (MESH:D006973,Disease) :: ['hypertension']
